Uveal melanoma.
Kashyap S, Meel R, Singh L, Singh M.
Semin Diagn Pathol. 2016 May;33(3):141-7. doi: 10.1053/j.semdp.2015.10.005. Epub 2016 Mar 10.
Uveal melanoma: estimating prognosis.
Kaliki S, Shields CL, Shields JA.
Indian J Ophthalmol. 2015 Feb;63(2):93-102. doi: 10.4103/0301-4738.154367.
Intraocular leiomyoma: Current concepts.
Tomar AS, Finger PT, Iacob CE.
Surv Ophthalmol. 2020 Jul-Aug;65(4):421-437. doi: 10.1016/j.survophthal.2019.12.008. Epub 2020 Jan 7.
Iris melanocytoma.
Radovanović AB, Krnjaja BD, Jaksić V.
Srp Arh Celok Lek. 2016 Jan-Feb;144(1-2):74-6. doi: 10.2298/sarh1602074b.
Updates in imaging in ocular oncology.
Davila JR, Mruthyunjaya P.
F1000Res. 2019 Oct 1;8:F1000 Faculty Rev-1706. doi: 10.12688/f1000research.19979.1. eCollection 2019.
The uvea.
O'Connor GR.
Arch Ophthalmol. 1973 Jun;89(6):505-17. doi: 10.1001/archopht.1973.01000040507014.
Obstacles to improving outcomes in the treatment of uveal melanoma.
Tsai KK, Bollin KB, Patel SP.
Cancer. 2018 Jul 1;124(13):2693-2703. doi: 10.1002/cncr.31284. Epub 2018 Mar 26.
Uveal melanoma: proton beam irradiation.
Gragoudas ES, Marie Lane A.
Ophthalmol Clin North Am. 2005 Mar;18(1):111-8, ix. doi: 10.1016/j.ohc.2004.08.002.
Thermography in clinical ophthalmic oncology.
Modrzejewska A, Cieszyński Ł, Zaborski D, Parafiniuk M.
Arq Bras Oftalmol. 2021 Jan-Feb;84(1):22-30. doi: 10.5935/0004-2749.20210004.
Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P, Miyamoto D, Goyeneche A, de Alba Graue PG, Jin E, Tsering T, Dias AB, Burnier MN, Burnier JV.
Cancer Med. 2019 Dec;8(17):7265-7277. doi: 10.1002/cam4.2594. Epub 2019 Oct 7.
